Evidence map›Paper›PMID 35082627›Full record

ArticleCase reports in oncology

A Successful Chemoembolization of a Retroperitoneal Soft Tissue Sarcoma: A Case Report.

Waldec Jorge David Filho, Angel Ayumi Tome Uchiyama, Catarina Marchon, Letícia Maria Duarte Lopes, Ana Luísa de Castro Baccarin, Bruna de Fina, Ricardo Virgílio Dos Santos, Francisco Leonardo Galastri

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.1field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Waldec Jorge David FilhoOncology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Angel Ayumi Tome UchiyamaOncology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Catarina MarchonOncology, Hospital Alemão Oswaldo Cruz, São Paulo, Brazil.
Letícia Maria Duarte LopesOncology, Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil.
Ana Luísa de Castro BaccarinOncology, Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil.
Bruna de FinaVascular, Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil.
Ricardo Virgílio Dos SantosVascular, Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil.
Francisco Leonardo GalastriVascular, Instituto Brasileiro de Controle do Câncer, São Paulo, Brazil.
Instituto Brasileiro de Controle do Câncer · BRHospital Alemão Oswaldo Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Retroperitoneal sarcomas are rare entities. They have a tendency of growing slowly, rendering the patient apparently healthy for long periods of time, before diagnosis. Besides, they have a worse prognosis than sarcomas arising in extremities, with a higher local recurrence rate and lower 5-year survival rate. We describe a case of a 71-year-old male patient, who had a very well succeeded treatment of a large retroperitoneal sarcoma with the combination of chemoembolization, systemic chemotherapy, surgery, and radiation therapy. Initially, it was noticed in an incidental way he had a large retroperitoneal mass (15 cm × 10 cm × 9.2 cm) through magnetic resonance, when he was 63. The case was considered inoperable by the treating physicians. After neoadjuvant therapy, the residual tumor could be completely excised by the responsible surgeon. With a follow-up of >5 years, since the end of treatment, the patient remains in complete remission and, probably, cured from his illness. Large retroperitoneal sarcomas are still a great challenge for oncologists. According to the medical literature, chemoembolization can benefit some patients, but most of them in a palliative setting. In our report, we believe its contribution was critical for a great outcome. In selected cases, it is possible this procedure may be an additional therapeutic modality, as part of a multidisciplinary approach.

Indexed as

Chemoembolization Retroperitoneal sarcoma

Identifiers

PMID35082627
PMCPMC8740223
OpenAlexW3216955559

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.